Royce & Associates LP acquired a new stake in Maximus, Inc. (NYSE:MMS – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 111,410 shares of the health services provider’s stock, valued at approximately $9,617,000. Royce & Associates LP owned about 0.20% of Maximus as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of the business. Richardson Financial Services Inc. grew its position in Maximus by 29.6% in the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after acquiring an additional 103 shares during the last quarter. Farther Finance Advisors LLC grew its position in Maximus by 69.0% in the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 116 shares during the last quarter. Arizona State Retirement System grew its position in Maximus by 0.9% in the 3rd quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock valued at $1,524,000 after acquiring an additional 156 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Maximus by 13.8% in the 4th quarter. GAMMA Investing LLC now owns 1,522 shares of the health services provider’s stock worth $131,000 after buying an additional 185 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Maximus by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after buying an additional 221 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.
Insider Buying and Selling
In other Maximus news, Director Jan Madsen sold 742 shares of the stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the completion of the sale, the director directly owned 20,795 shares in the company, valued at approximately $1,502,438.75. This trade represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.80% of the company’s stock.
Maximus Trading Up 1.3%
Maximus (NYSE:MMS – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.98 by $0.09. The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm’s quarterly revenue was down 4.1% on a year-over-year basis. During the same period in the prior year, the business posted $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Equities research analysts expect that Maximus, Inc. will post 8.43 EPS for the current fiscal year.
Maximus Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be paid a $0.33 dividend. The ex-dividend date is Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.1%. Maximus’s dividend payout ratio (DPR) is 19.76%.
Analyst Upgrades and Downgrades
A number of research firms have recently issued reports on MMS. Weiss Ratings downgraded Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Finally, Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of “Hold”.
View Our Latest Stock Analysis on MMS
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Articles
- Five stocks we like better than Maximus
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
